LONDON, July 29, 2026 - Significant advancements have been made in the strategic and financial objectives through the implementation of the Value Creation Plan. The focus has been refined and the financial profile has been improved with the recent divestiture of the Life Sciences & Healthcare segment. The outlook for 2026 has been reinforced, demonstrating a positive trajectory for the future.